Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Translational Oncology|October 3, 2020
9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Laura L Stafman, et al.
Oncotarget|June 2, 2018
Targeting PIM kinase as a therapeutic strategy in human hepatoblastomaLaura L Stafman, Smitha Mruthyunjayappa, Alicia M Waters, et al.
Journal of Pediatric Surgery|March 25, 2021
Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Colin H Quinn, et al.
Osteoarthritis and Cartilage|May 18, 2020
Individuals with high bone mass have increased progression of radiographic and clinical features of knee osteoarthritisA Hartley, S A Hardcastle, L Paternoster, et al.
Scientific Reports|March 17, 2021
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastomaRaoud Marayati, Laura L Stafman, Adele P Williams, et al.
Cell Death & Disease|January 15, 2026
PP2A activation targets MYCN in neuroblastomaNazia Nazam, Shamza Manzoor, Maryam Shaikh, et al.
Plos One|March 10, 2021
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growthLaura V Bownes, Adele P Williams, Raoud Marayati, et al.
Scientific Reports|September 15, 2019
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived XenograftsLaura L Stafman, Adele P Williams, Raoud Marayati, et al.
Pageof 9